| Literature DB >> 31069099 |
Robert A Cates1, Andrea J Boon2, Robert T Trousdale1, Altagrace Douge2, Rafael J Sierra1.
Abstract
Periacetabular osteotomies (PAOs) are used to treat acetabular dysplasia in younger patients, but are not without morbidity. Lateral femoral cutaneous nerve (LFCN) injuries are commonly associated with the approach for PAOs, but the true incidence and rate of resolution is not known. The purpose of this prospective study was to determine the incidence of LFCN injuries after PAO using an innovative nerve conduction study (NCS) and to report the patient-reported outcomes. We prospectively enrolled 23 patients (24 hips) undergoing PAOs to have pre- and post-operative NCSs at a mean of 12 weeks post-operative. Patients were followed prospectively. Patients were contacted 3 years post-operatively via phone to determine the presence and severity of symptoms. Patient-reported outcome scores were also correlated with patient symptoms. Patients (91%) reported one or more LFCN symptoms post-operatively. The most common symptoms were numbness (91%), tingling (36%), pain (18%) and burning (9%). Patients (67%) had evidence of LFCN injury based on NCSs. Symptoms (40%) resolved 4 months post-operatively. Two-thirds of patients had continued symptoms at 3 years. Only 1 patient required treatment. The incidence of LFCN injury after PAO is 90%, two-thirds of which can be identified objectively by NCS. Numbness is the most common symptom. LFCN symptoms (40%) resolve by 4 months, but two-thirds of patients may continue to have thigh numbness up to 3 years after surgery. Fortunately, symptoms are not clearly associated with outcome score and treatment for this complication is rare.Entities:
Year: 2019 PMID: 31069099 PMCID: PMC6501446 DOI: 10.1093/jhps/hny050
Source DB: PubMed Journal: J Hip Preserv Surg ISSN: 2054-8397
Patient demographics
| Patient | Age (years) | Side | Sex | BMI (kg/m2) | Concomitant procedure | Pre-existing injury | Pre-operative diagnosis | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 25 | R | F | 20.1 | None | Dysplasia | |||
| 2 | 29 | R | F | 22.6 |
| Yes, previous hip arthroscopy | Dysplasia, s/p hip scope | ||
| 3 | 23 | R | F | 34.6 |
| Dysplasia | |||
| 4 | 28 | R | F | 27.4 | None | Dysplasia | |||
| 5 | 24 | L | F | 40.7 |
| Acetabular retroversion | |||
| 6 | 15 | R | F | 23.0 | None | Dysplasia | |||
| 7 | 25 | L | M | 22.5 |
| Dysplasia | |||
| 7 | 25 | R | M | 22.5 |
| Dysplasia | |||
| 8 | 36 | R | F | 29.2 |
| Dysplasia | |||
| 9 | 34 | R | F | 21.2 |
| Dysplasia, s/p hip scope | |||
| 10 | 17 | R | M | 22.3 |
| Acetabular retroversion | |||
| 11 | 20 | R | F | 25.9 |
| Dysplasia | |||
| 12 | 26 | L | F | 19.7 |
| Dysplasia, s/p hip scope | |||
| 13 | 26 | R | F | 30.2 |
| Yes, motorcycle accident | Acetabular retroversion, s/p trauma | ||
| 14 | 41 | L | F | 23.2 |
| Dysplasia | |||
| 15 | 20 | L | F | 17.7 |
| Yes, lumbar etiology | Acetabular retroversion | ||
| 16 | 19 | L | M | 24.4 |
| Acetabular retroversion | |||
| 17 | 36 | L | F | 32.1 |
| Dysplasia | |||
| 18 | 16 | R | F | 23.1 |
| Dysplasia | |||
| 19 | 25 | R | F | 20.2 |
| Dysplasia | |||
| 20 | 18 | L | F | 28.1 | None | Dysplasia | |||
| 21 | 21 | L | F | 20.4 |
| Acetabular retroversion | |||
| 22 | 22 | R | M | 29.3 |
| Dysplasia | |||
| 23 | 19 | R | F | 18.4 |
| Acetabular retroversion | |||
| Mean | 24.7 | 15 | 9 | 4 | 19 | 24.96 | |||
| SD | 6.78 | 5.56 | |||||||
Osteochondroplasty.
labral debridement.
anterior inferior iliac spine trimming.
labral repair.
surgical hip dislocation.
Nerve conduction studies
| Patient | Pre-operative NCS | Post-operative NCS | NCS follow-up (weeks) | Amp change (%) | Lat change (%) | LFCN injury | |||
|---|---|---|---|---|---|---|---|---|---|
| Amp (μV) | Lat (ms) | Amp (μV) | Lat (ms) | ||||||
| 1 | 12.0 | 2.10 | NR | NR | 13 | — | — | Yes | |
| 2 | 21 | 2.0 | NR | NR | 12 | — | — | Yes | |
| 3 | 3 | 2.3 | 4 | 2.0 | 8 | 33.3 | −13.0 | No | |
| 4 | 3 | 2.5 | 2 | 2.8 | 10 | −33.3 | 12.0 | No | |
| 5 | 9 | 1.6 | NR | NR | 9 | — | — | Yes | |
| 6 | 6 | 2.7 | 4 | 2.4 | 8 | −33.3 | −11.1 | Yes | |
| 7 | 18 | 1.8 | 9 | 2.1 | 6 | −50.0 | 16.7 | Yes | |
| 7 | 22 | 2.1 | NR | NR | 25 | — | — | Yes | |
| 8 | 9 | 2.0 | NR | NR | 9 | — | — | Yes | |
| 9 | 7 | 2.1 | 3 | 2.0 | 8 | −57.1 | −4.8 | Yes | |
| 10 | 26 | 2.2 | NR | NR | 9 | — | — | Yes | |
| 11 | 19 | 1.8 | 11 | 1.8 | 10 | −42.1 | 0.0 | No | |
| 12 | 11 | 2.2 | NR | NR | 11 | — | — | Yes | |
| 13 | 5 | 1.8 | NR | NR | 13 | — | — | Yes | |
| 14 | 9 | 1.8 | NR | NR | 10 | — | — | Yes | |
| 15 | 15 | 2.3 | 11 | 2.5 | 13 | −26.7 | 8.7 | No | |
| 16 | 21 | 1.8 | 9 | 2.3 | 11 | −57.1 | 27.8 | No | |
| 17 | NR | NR | 5 | 2.8 | 49 | — | — | No | |
| 18 | 11 | 1.8 | 11 | 2.0 | 7 | 0.0 | 11.1 | No | |
| 19 | 7 | 2.2 | NR | NR | 12 | — | — | Yes | |
| 20 | 46 | 2.0 | 2 | 2.2 | 13 | −95.7 | 10.0 | Yes | |
| 21 | 4 | 2.5 | NR | NR | 11 | — | — | Yes | |
| 22 | 4 | 2.2 | 3 | 2.4 | 9 | −25.0 | 9.1 | No | |
| 23 | 12 | 1.6 | NR | NR | 6 | — | — | Yes | |
| Mean | 13 | 2.1 | 6.2 | 2.3 | 12.02 | 16 | 8 | ||
| SD | 9.86 | 0.29 | 3.71 | 0.32 | 8.75 | ||||
NCS, nerve conduction study; NR, no response; Lat, latency; Amp, amplitude.
Patient phone-call follow-up
| Patient | F/U months | Initial symptoms | Remaining symptoms | Resolved symptoms | Time (months) | Worst severity | Severity at F/U | Treatment |
|---|---|---|---|---|---|---|---|---|
| 1 | 30.5 |
|
| – | 2 | |||
| 2 | 36.4 |
|
| 4 | 1 | |||
| 3 | 33.3 |
|
| 8 | 2 | |||
| 4 | 35.5 |
| None |
| 3.5 | 2 | 0 | |
| 5 | 35.4 |
| None |
| 6 | 5 | 0 | |
| 6 | 38.7 |
|
|
| 5 | 2 | ||
| 7 | 35.0 |
| None |
| 2 | 1 | 0 | |
| 7 | 33.6 |
|
| 10 | 10 | Yes | ||
| 8 | 35.4 |
|
| 8 | 2 | |||
| 9 | 35.7 | None | None | |||||
| 10 | 36.5 |
|
| 3 | 1 | |||
| 11 | 33.4 |
| None |
| 2 | 7 | 0 | |
| 12 | 36.3 |
|
| 8 | 3 | |||
| 13 | 36.3 |
|
| 7 | 4 | |||
| 14 | 29.3 |
|
| 10 | 4 | |||
| 15 | 33.7 | None | ||||||
| 16 | 33.8 |
| None |
| 1.5 | 3 | 0 | |
| 17 | 28.9 |
|
|
| 7 | 1 | ||
| 18 | 32.0 |
|
|
| 8 | 1 | ||
| 19 | 30.9 |
|
|
| 3 | 1 | ||
| 20 | 37.9 |
| None |
| 1.5 | 5 | 0 | |
| 21 | 39.2 |
| None |
| 12 | 4 | 0 | |
| Mean | 34.4 | 4.1 | 5.68 | 1.7 | ||||
| SD | 2.83 | 3.85 | 2.67 | 2.34 |
Numbness.
tingling.
pain.
burning.
gabapentin, neurolysis, pain pump, acupuncture, manipulation, injections.